All Stories

  1. Report from the 2025 research showcase and open discussion on equine vector‐borne diseases in the UK
  2. Mitochondrial DNA sequencing of horse breeds found in north-west Nigeria
  3. Effectiveness of a screening protocol employed at a UK rescue centre to prevent introduction of strangles
  4. Report from the 2025 research showcase & open discussion on equine vector-borne diseases in the UK
  5. Development and optimisation of Influenza C and Influenza D pseudotyped viruses
  6. Understanding the Molecular Interactions Between Influenza A Virus and Streptococcus Proteins in Co-Infection: A Scoping Review
  7. Should the equine community be concerned about the emergence of the H5N1 subtype of highly pathogenic avian influenza in US cattle?
  8. The Value of a Comparative Approach with Equine Vaccine Development for the Development of Human Influenza DNA Vaccines
  9. Role of pseudotyped viruses in understanding epidemiology, pathogenesis and immunity of viral diseases affecting both horses and humans
  10. Modelling the Influence of Climate and Vector Control Interventions on Arbovirus Transmission
  11. A systematic review quantifying host feeding patterns ofCulicoidesspecies responsible for pathogen transmission
  12. The Potential of Plant-Produced Virus-like Particle Vaccines for African Horse Sickness and Other Equine Orbiviruses
  13. Knowns and unknowns of TiLV-associated neuronal disease
  14. Development of Virus-like Particle Plant-Based Vaccines against Avian H5 and H9 Influenza A Viruses
  15. Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy
  16. Advances in the understanding, detection and management of equine strangles
  17. Tilapia Lake Virus Vaccine Development: A Review on the Recent Advances
  18. Therapeutic Phage Display-Derived Single-Domain Antibodies for Pandemic Preparedness
  19. The persistence of equine strangles
  20. Seroprevalence of Equine Influenza and Its Associated Risk Factors in Northwest Nigeria
  21. An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation
  22. Inference for a spatio-temporal model with partial spatial data: African horse sickness virus in Morocco
  23. Gene Expression Profile Induced by Two Different Variants of Street Rabies Virus in Mice
  24. Development of Plant-Based Vaccines for Prevention of Avian Influenza and Newcastle Disease in Poultry
  25. Re‐parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search
  26. Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes
  27. A Scoping Review of West Nile Virus Seroprevalence Studies among African Equids
  28. Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study
  29. Retrospective serological survey for influenza in horses from Brazil
  30. Systematic review and meta‐analysis of seroprevalence studies of West Nile virus in equids in Europe between 2001 and 2018
  31. Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
  32. Serosurvey of pandemic H1N1 influenza A virus in dogs in Andalusia (southern Spain)
  33. Equine viral encephalitis: prevalence, impact, and management strategies
  34. Bluetongue virus outer-capsid protein VP2 expressed in Nicotiana benthamiana raises neutralising antibodies and a protective immune response in IFNAR −/− mice
  35. The challenges posed by equine arboviruses
  36. Strategic implementation of vaccines for control of equine influenza
  37. The Optimisation of Pseudotyped Viruses for the Characterisation of Immune Responses to Equine Influenza Virus
  38. The Influenza NS1 Protein: What Do We Know in Equine Influenza Virus Pathogenesis?
  39. Canine parvovirus study
  40. Making sense of altmetrics
  41. Controlling equine influenza: Traditional to next generation serological assays
  42. Small animal disease surveillance: respiratory disease
  43. Modulation of Potassium Channels Inhibits Bunyavirus Infection
  44. Technical considerations for the generation of novel pseudotyped viruses
  45. Diversity of group A rotavirus on a UK pig farm
  46. Seroprevalence of Schmallenberg virus in the United Kingdom and the Republic of Ireland: 2011–2013
  47. In memoriam – Richard M. Elliott (1954–2015)
  48. Comparison of Schmallenberg virus antibody levels detected in milk and serum from individual cows
  49. Identification of morphological differences between avian influenza A viruses grown in chicken and duck cells
  50. High Basal Expression of Interferon-Stimulated Genes in Human Bronchial Epithelial (BEAS-2B) Cells Contributes to Influenza A Virus Resistance
  51. Development of a surveillance scheme for equine influenza in the UK and characterisation of viruses isolated in Europe, Dubai and the USA from 2010–2012
  52. Pseudotypes: your flexible friends
  53. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy
  54. The genetics of virus particle shape in equine influenza A virus
  55. Wildlife Vectors of Schmallenberg?
  56. What can mathematical models bring to the control of equine influenza?
  57. Current progress with serological assays for exotic emerging/re-emerging viruses
  58. SBV transmission
  59. Evolution of Equine Influenza Virus in Vaccinated Horses
  60. Testing for Schmallenberg Virus
  61. Schmallenberg virus
  62. Neuraminidase inhibitors for treatment of equine influenza – when all else fails?
  63. Recombination and positive selection identified in complete genome sequences of Japanese encephalitis virus
  64. herpesviruses in Egyptian rodents
  65. Antigenic and Genetic Evolution of Equine Influenza A (H3N8) Virus from 1968 to 2007
  66. Equine influenza: A review of an unpredictable virus
  67. Evaluation of two commercially available ELISAs for the diagnosis of Japanese encephalitis applied to field samples
  68. Intra- and Interhost Evolutionary Dynamics of Equine Influenza Virus
  69. Dynamics of Influenza Virus Infection and Pathology
  70. Quantifying the Impact of Immune Escape on Transmission Dynamics of Influenza
  71. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007
  72. Control of equine influenza: scenario testing using a realistic metapopulation model of spread
  73. Vaccine failure caused an outbreak of equine influenza in Croatia
  74. Transmission of Equine Influenza Virus to English Foxhounds
  75. Protection, systemic IFNγ, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host
  76. Risk factors for influenza infection in vaccinated racehorses: Lessons from an outbreak in Newmarket, UK in 2003
  77. New assays to measure equine influenza virus-specific Type 1 immunity in horses
  78. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short‐term vaccine efficacy study
  79. Frequency and phenotype of EHV-1 specific, IFN-γ synthesising lymphocytes in ponies: The effects of age, pregnancy and infection
  80. Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
  81. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
  82. Vaccination against equine influenza: Quid novi?
  83. Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection
  84. Investigation of Equine Influenza Cases Exhibiting Neurological Disease: Coincidence or Association?
  85. Evaluation of the Binax NOW Flu A test kit for the rapid detection of equine influenza virus
  86. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease
  87. Equine influenza in dogs: Too late to bolt the stable door?
  88. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses
  89. Inhaled Zanamivir Versus Rimantadine for the Control of Influenza in a Highly Vaccinated Long-term Care Population
  90. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1
  91. Characterisation of three equine influenza A H3N8 viruses from Germany (2000 and 2002): Evidence for frozen evolution
  92. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an ‘American lineage’ H3N8 virus
  93. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines
  94. The effects of strain heterology on the epidemiology of equine influenza in a vaccinated population
  95. Current perspectives on control of equine influenza
  96. Unifying the Epidemiological and Evolutionary Dynamics of Pathogens
  97. Comparison of hamster and pony challenge models for evaluation of effect of antigenic drift on cross protection afforded by equine influenza vaccines
  98. Optimising vaccination strategies in equine influenza
  99. Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred
  100. Influenza HA DNA induces Th1 cells and protection despite limited antibody responses
  101. Methods for determining resistance to neuraminidase inhibitors
  102. Viral Infections of the Equine Respiratory Tract
  103. Correspondence
  104. Antigenic and genetic evolution of equine H3N8 influenza A viruses
  105. Genetic and Antigenic Analysis of the Influenza Virus Responsible for the 1992 Hong Kong Equine Influenza Epizootic
  106. Genetic and antigenic analysis of an equine influenza H 3 isolate from the 1989 epidemic